A NEW CANCER THERAPY: MULTI-APPLICATION OF MULTI-WALLED CARBON NANOTUBES FOR MAGNETIC RESONANCE TEMPERATURE IMAGING GUIDED LASER INDUCED THERMAL THERAPY

Product Description
In this work multi-application, multi-walled carbon nanotubes (MWCNTs) as super MR contrast agents and Near-Infared Radiation (NIR) laser absorbers are combined with Proton Resonance Frequency (PRF) based Magnetic Resonance Temperature Imaging (MRTI) to improve the safety and efficacy of Laser Induced Thermal Therapy (LITT). Instilled MWCNTs enable precise tumor localization and killing of the tumor through preferential high temperature while protecting surrounding healthy tissue by monitoring the 3D temperature distribution. As advanced MR contrast agents (CA), Fe-containing MWCNTs produced by chemical vapor deposition (CVD) with 600mg Ferrocene, show up to 5 times greater efficiency in changing T2 relaxation properties compared to the clinical MR CA, Feridex. Thus, MWCNTs could be used potentially as a super heating generator and contrast agents in thermal ablation therapy.

BUY FROM AMAZON–>> A NEW CANCER THERAPY: MULTI-APPLICATION OF MULTI-WALLED CARBON NANOTUBES FOR MAGNETIC RESONANCE TEMPERATURE IMAGING GUIDED LASER INDUCED THERMAL THERAPY

New Report On Medical Imaging Markets: Contrast Agents Added In Visionshopsters

The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.

Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of imaging equipment, it has not had a significant negative impact on the use of contrast agents with the equipment already on hand. Specifically, annual growth for medical contrast media during the next five years appears to be strong, despite the recession slowing capital equipment purchases. Imaging exams are still needed for many diagnoses, and contrast enhancement facilitates diagnosis in many cases. Kalorama expects growth ranges to remain high.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama’s medical imaging market reports. Coverage includes:

World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2012. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

Market share of the major contrast agent supplers

Procedure volumes by modality and region

Estimates of the portion of procedures in each modality using contrast enhancement

Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

Acusphere Inc.

Alseres Pharmaceuticals Inc.

Amag Pharmaceuticals Inc.

Aposense Ltd.

Avid Radiopharmaceuticals Inc.

Bayer Schering Pharma

Bracco SpA

Cell Point

Covidien Ltd.

Daiichi Pharmaceutical Co. Ltd.

Dendritic NanoTechnologies Inc.

Draximage

Endocyte Inc.

Eusa Pharma

GE Healthcare

Guerbet Group

Hovione FarmaCiencia SA

Imcor Pharmaceutical Co.

Immunomedics Inc.

Insight Agents GmbH

King Pharmaceuticals Inc.

Luna nanoWorks

Macrocyclics

MDS Nordion

NanoScan Imaging

Palatin Technologies Inc.

Pharmacyclics

Point Biomedical Corp.

Starpharma Holdings Ltd.

VisEn Medical Inc.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1659/Medical-Imaging-Markets-Contrast-Agents.html

Contact Us:

Visionshopsters
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

MAGNETIC NANOTUBES AS MAGNETIC RESONANCE CONTRAST AGENTS: Sythesis, Characterization, Cytotoxicity and Cellular Uptake

Product Description
An increasing interest in medical application of nanotechnology has heightened the need for synthesis of nanoparticles with well-defined dimensions and multifunctionalities. Based on template synthesis method, magnetic nanotubes (MNT) were successfully prepared with precise morphology control. The MNTs have super magnetic properties, including high saturation magnetization and magnetic resonance relaxivities. Cytotoxicity and cellular uptake of SNTs were investigated for primary and cancer cells. The nanotubes showed limited toxicity which was concentration-, surface charge-, and length- dependent. The internalization was confirmed with both confocal microscopy and TEM studies. These studies were directed by Professor Sang Bok Lee.

BUY FROM AMAZON–>> MAGNETIC NANOTUBES AS MAGNETIC RESONANCE CONTRAST AGENTS: Sythesis, Characterization, Cytotoxicity and Cellular Uptake

Dendrimer-Based Nanomedicine

Product Description
In recent decades, dendrimers — free-shaped synthetic macromolecules — have garnered a great deal of scientific interest due to their unique molecular nanostructure. Used in a variety of scientific applications, the use of dendrimers is now widely regarded as a safer, more precise, and more effective way to practice medicine.

This book compiles and details cutting-edge research in science and medicine from the interdisciplinary team of the Michigan Nanotechnology Institute for Medicine and Biological Sciences, who are currently revolutionizing drug delivery techniques through the development of engineered nanodevices. Edited by Istvan J Majoros and James Baker, Jr., two prominent nanotechnology researchers, this book will appeal to anyone involved in nanotechnology, macromolecular science, cancer therapy, or drug delivery research.

Contents: Targeted Drug Delivery in General, New Technology in Medicine (B B Ward & J R Baker, Jr.); General Carriers for Drug Delivery (T H Dunham et al.); Poly(amidoamine) Dendrimer Synthesis and Characterization (I J Majoros & D E Carter); Optical and Biophotonic Applications of Dendrimer Conjugate (J Y Ye & T B Norris); Dendrimer Conjugates for Cancer Treatment (I J Majoros et al.); Biological Application of PAMAM Dendrimer Nanodevices in vitro and in vivo (T P Thomas & J F Kukowska-Latallo); Dendrimer-based Targeted Apoptosis Sensors for Medical Application (A Myc et al.); MRI Using Targeted Dendrimer Contrast Agents (S D Swanson & C R Williams); Nanoparticle Membrane Interactions: Mechanism for Enhanced Permeability (S Hong et al.); Computer Simulations of Dendrimers (S K Kandasamy et al.); Dendrimer-Entrapped and Dendrimer-Stabilized Metal Nanoparticles for Biomedical Applications (X-Y Shi & S H Wang).

BUY FROM AMAZON–>> Dendrimer-Based Nanomedicine